Sponsor:
Immedica Pharma US Inc
Code:
NCT07573059
Conditions
ARG1 Deficiency
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Loargys Arginine Test System
Brief summary:
Conditions
ARG1 Deficiency
Study ID
NCT07573059
Start date
Apr 17, 2026
Status verified date
May, 2026
Completion date
Jul 15, 2027
Anticipated
Primary completion date
Jul 15, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Enrollment
100 participants
Anticipated
Intervention Model
Single group
Primary purpose
Other
Arms
other: Loargys Arginine Test System
Interventions
Loargys Arginine Test System
Primary outcome measure
Central contacts
Locations
Rare Disease Research
Recruiting
Atlanta, Georgia, United States, 303029
Contacts
Sponsor
Immedica Pharma US Inc
Last update posted
May 7, 2026
Last verified
May, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Immedica Pharma US Inc on 2026-05-07.